Stock Image
...

SANJIVIN

Sanjivani Paranteral Ltd

Industry: Pharmaceuticals

MarketCap: .... Rank : ...

Financials Yearly Financials Quarterly Holdings About Company Fundamental Chart Technical Chart



Financials


LTP : StockToolX | Last Financial Change : StockToolX


Financials Quarterly


Last Quarterly Change : StockToolX


Holdings


Last Holdings Change : StockToolX


About Sanjivani Paranteral Ltd

Overview

Sanjivani Paranteral Ltd. is a leading Indian pharmaceutical company that specializes in the manufacture of injectable and oral dosage forms. The company was founded in 1994 and is headquartered in Mumbai, Maharashtra. Sanjivani Paranteral has a strong portfolio of products, including generic and branded injectables, as well as oral formulations. The company's products are marketed in India and other countries around the world.

History

Sanjivani Paranteral was founded in 1994 by a group of experienced pharmaceutical professionals. The company's initial focus was on the manufacture of injectables, but it soon expanded into the oral dosage form market. Sanjivani Paranteral has grown rapidly over the past two decades, and it is now one of the leading pharmaceutical companies in India.

How the company operates

Sanjivani Paranteral has a vertically integrated manufacturing process. The company has its own API (active pharmaceutical ingredient) manufacturing facility, as well as formulation and packaging facilities. This allows Sanjivani Paranteral to maintain tight control over the quality of its products. The company also has a strong research and development team that is constantly working to develop new products.

The future

Sanjivani Paranteral is well-positioned for future growth. The company has a strong portfolio of products, a vertically integrated manufacturing process, and a dedicated research and development team. Sanjivani Paranteral is also expanding its global presence, and it is targeting new markets in Africa, Asia, and Latin America.

Conclusion

Sanjivani Paranteral is a leading Indian pharmaceutical company with a strong track record of growth. The company is well-positioned for future growth, and it is a good investment for investors who are looking for exposure to the Indian pharmaceutical market.

Official website:

Milestones:

  • 1994: Sanjivani Paranteral is founded.
  • 1999: The company's first product is launched.
  • 2005: Sanjivani Paranteral expands its manufacturing capacity.
  • 2010: The company enters the oral dosage form market.
  • 2015: Sanjivani Paranteral opens a new manufacturing facility in Navi Mumbai.
  • 2020: The company's products are marketed in over 50 countries around the world.
  • Additional information and interesting facts:

  • Sanjivani Paranteral is a public company that is listed on the Bombay Stock Exchange.
  • The company's CEO is Mr. Rakesh Shah.
  • Sanjivani Paranteral has a strong commitment to corporate social responsibility. The company supports a number of social initiatives, including education and healthcare programs.
  • Brands and companies:

  • Sanjivani Paranteral's brands include Sanjivin, Sanjif, and Sanjeev.
  • The company's products are marketed by a number of distributors and wholesalers around the world.
  • Read More
    Read Less

    Company Details : 2 Weeks Ago StockToolX


    Sanjivani Paranteral Ltd Fundamental Analysis

    Score : ?

    History :

    Score:
    Price:
    Trend:
    Fundamental Score Updated : 4 Hours ago StockToolX


    Sanjivani Paranteral Ltd Technical Analysis

    Score : ?

    History :

    Score:
    Price:
    Trend:
    1/10
    2/10
    4/10
    3/10


    Technical Score Updated : StockToolX